April 23, 2026Blood Cancer Discovery0 citations
Outstanding Questions to Understand and Target Splicing Factor–Mutant Blood Cancers
View Full Paper
Key Points
- This commentary aims to address the unresolved issues regarding the link between splicing factor mutations and blood cancers.
- Discussion of existing literature regarding RNA splicing factors and their mutations.
- Analysis of the link between splicing factor mutations and myeloid malignancies and chronic lymphocytic leukemia.
- Exploration of potential therapeutic approaches targeting these mutations.
- Identifies gaps in the understanding of how splicing factor mutations contribute to blood cancers.
- Highlights ongoing efforts to develop targeted therapies for cancers driven by these mutations.
- Encourages further research to elucidate the mechanisms behind these mutations.
Abstract
Summary: Mutations in genes encoding RNA splicing factors are common in patients with myeloid malignancies and chronic lymphocytic leukemia. In this commentary, we discuss key unanswered questions on the causal role of these mutations in blood cancers and precursor conditions as well as efforts to develop therapies targeting these high-frequency neomorphic mutations.